Laurus Labs Ltd.
SET SMS ALERT
| 5-Day | 4,694 |
| 10-Day | 3,572 |
| 30-Day | 338,457 |
| 5-Day | 4,694 |
| 10-Day | 3,572 |
| 30-Day | 338,457 |
Depth
Market Depth (22 Apr 2019)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 20 | 385.15 | 388.45 | 19 |
| 110 | 385.05 | 388.50 | 1 |
| 100 | 385.00 | 389.10 | 10 |
| 94 | 384.75 | 389.45 | 20 |
| 5 | 384.50 | 390.00 | 1 |
| 1818 | Total | 1120 | Total |
Buy Qty
1818
Sell QTY
1120
| 5-Day | 57,506 |
| 10-Day | 55,476 |
| 30-Day | 258,783 |
| 5-Day | 57,506 |
| 10-Day | 55,476 |
| 30-Day | 258,783 |
- Quote
- CHARTS
- NEWS
- COMMENTS2 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Laurus Labs
Sentimeter
100% of moneycontrol users recommend buying Laurus Labs.
What's your call on Laurus Labs today?
Read 2 investor views
| Days | BSE | NSE |
| 30 | 386.50 | 386.47 |
| 50 | 366.86 | 366.84 |
| 150 | 381.00 | 380.80 |
| 200 | 398.76 | 398.63 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Laurus Labs
| Standalone | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
| Net Sales | 512.78 | 574.63 | 531.10 | 546.55 |
| Other Income | 1.41 | 10.51 | 2.58 | 5.01 |
| PBDIT | 85.67 | 75.16 | 78.29 | 114.44 |
| Net Profit | 17.48 | 17.63 | 15.93 | 46.35 |
Annual Report
(In Rs Cr)
| Total Share Capital | 106.03 |
| Net Worth | 1,513.30 |
| Total Debt | 867.72 |
| Net Block | 1,447.69 |
| Investments | 51.74 |
| Total Assets | 2,381.02 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 454.50 | -1.64 | 678.80 | 375.40 | 109,049.77 |
| Piramal Enter | 2554.85 | -3.73 | 3302.55 | 1796.75 | 47,123.43 |
| Dr Reddys Labs | 2800.00 | -0.03 | 2875.00 | 1888.00 | 46,498.47 |
| Aurobindo Pharm | 778.60 | -1.05 | 830.00 | 527.05 | 45,619.39 |
| Divis Labs | 1705.05 | -1.18 | 1767.10 | 994.95 | 45,263.72 |
| More » | |||||
| Mar' 19 | Dec' 18 | Dec' 18 | Jun' 18 | |
| Promoter | 32.77 | 33.50 | 33.50 | 32.06 |
| Public (FII + DII) | 67.23 | 66.50 | 66.50 | 67.94 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
HDFC Bank Recommended on Jun 5th 2017
Recommended price 1,636.00 | Peak from reco 2332.35 42.58%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Laurus Labs
Laurus Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4,098.35 crore.
The company management includes M Venu Gopala Roa - Non Exe.Chairman&Ind.Director, Satyanarayana Chava - Executive Director & CEO, Ravi Kumar Venkata Vantaram - Executive Director & CFO, Chandrakanth Chereddi - Executive Director, C V Lakshmana Rao - Executive Director, Narendra Ostawal - Director, Aruna Rajendra Bhinge - Independent Director, Rajesh Koshy Chandy - Independent Director, Ramesh Subrahmanian - Independent Director, Ravindranath Kancherla - Independent Director.
It is listed on the BSE with a BSE Code of 540222 and the NSE with an NSE Code of LAURUSLABS.
Its Registered office is at Plot No.21 & 18, Jawaharlal Nehru Pharma City,
,Parawada, Vishakapatnam,Andhra Pradesh - 531021.
Their Registrars are Karvy Fintech Pvt. Ltd.
